MOG and myeloid sarcoma: As a caveat, CNS lesions in both NMOSD (~ 15%) and MOG-EM/MOGAD (~ 40% at least once in the course of disease in a European cohort [84]) may formally meet the Barkhof or Swanton criteria for MS in some cases.